Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of two-dose live attenuated varicella vaccine in adolescents and adults
ChiCTR2500098374Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Mar 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of varicella vaccine live in chickenpox (12 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoints: Antibody positive conversion rate and Antibody geometric mean titer. Started Mar 2025; status: completed.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on ChiCTR2500098374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098374.